Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-21-012155
Filing Date
2021-06-14
Accepted
2021-06-14 16:01:36
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162370087522493.html 3  
1 FORM 3 wf-form3_162370087522493.xml 3 1655
  Complete submission text file 0001628280-21-012155.txt   3315
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET STAMFORD CT 06902
Business Address
Mohindru Mani (Reporting) CIK: 0001664708 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35558 | Film No.: 211014573